|
Volumn 4, Issue 2, 2002, Pages 117-121
|
Bone mineral density in hypogonadal men remains low after long-term testosterone replacement
a a a a a |
Author keywords
Androgen replacement therapy; Bone mineral density; Male hypogonadism
|
Indexed keywords
ALKALINE PHOSPHATASE;
ANDROGEN;
CHORIONIC GONADOTROPIN;
DEOXYPYRIDINOLINE;
ENARMONE DEPOT 250;
GONADOTROPIN;
TESTOSTERONE ENANTATE;
DRUG DERIVATIVE;
TESTOSTERONE;
ADULT;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ANDROGEN THERAPY;
ARTICLE;
BONE DEFECT;
BONE DENSITY;
BONE DEVELOPMENT;
BONE MINERAL;
CLINICAL ARTICLE;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
GONADOTROPIN DEFICIENCY;
HORMONE SUBSTITUTION;
HUMAN;
HYPOGONADISM;
KALLMANN SYNDROME;
MALE;
OSTEOPENIA;
TESTIS DISEASE;
TRABECULAR BONE;
AGE;
COMPARATIVE STUDY;
CRYPTORCHISM;
DRUG EFFECT;
INTRAMUSCULAR DRUG ADMINISTRATION;
MIDDLE AGED;
PATHOPHYSIOLOGY;
REFERENCE VALUE;
ADULT;
AGE FACTORS;
BONE DENSITY;
COMPARATIVE STUDY;
CRYPTORCHIDISM;
HORMONE REPLACEMENT THERAPY;
HUMAN;
HYPOGONADISM;
INJECTIONS, INTRAMUSCULAR;
KALLMANN SYNDROME;
MALE;
MIDDLE AGE;
REFERENCE VALUES;
TESTOSTERONE;
HUMANS;
MIDDLE AGED;
|
EID: 0035987237
PISSN: 1008682X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (21)
|